Pharmaceutical Company Commends Advanced of the Year
Release time:
2020-08-14
Pharmaceutical Company Commends Annual Advanced
News 1# July 29 Afternoon, Peak Pharmaceutical Company Held 2017 Annual Summary Commendation Meeting to Summarize the Work of the Past Year, Commend the Outstanding Collectives and Individuals of Pharmaceutical Company 2017 , and Put forward the Work Ideas for the New Year.
2017 is an important year to deepen the reform in an all-round way. The pharmaceutical industry is in a period of policy adjustment and turbulence , . The frequent occurrence of national pharmaceutical policies, especially the continuous promotion of the new medical reform policy and the rapid landing of drug regulatory policies, have brought new opportunities and challenges to the pharmaceutical industry. In the face of the complex and changeable industrial situation and market environment, the pharmaceutical company closely revolves around the business objectives set at the beginning of the year, seizes the opportunity of industry integration and market expansion, carries out all kinds of work in a down-to-earth manner, and achieves good results. On behalf of the management team of the pharmaceutical company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made a work report entitled "comply with new policies, meet new challenges, gather new forces to achieve new leaps". He made a report on the completion of economic indicators, scientific and technological innovation achievements, brand promotion of enterprises and products, enterprise expansion, completion and use of technological transformation projects, strengthening of internal management and refinement of marketing work, the party-mass work and other aspects reviewed the main work in 2017
2018 . He pointed out that 2018 is a very critical year for the pharmaceutical industry. The newly revised Drug Administration Law will be implemented, and the drug registration management measures, drug technology transfer management measures, drug marketing license holder system, GMP and GSP certification systems will be revised accordingly. With the continuous introduction of policies, the entire industry will undergo tremendous changes. Pharmaceutical companies will proceed from the actual situation of the company, fully tap their own advantages, take innovation and standardization as the main line, and steadily advance various tasks. At the meeting, he made arrangements for the key work of 2018 . Chairman of the Group Company and Chairman of the Pharmaceutical Company Jiang Xiaomeng, Chairman of the Trade Union of the Group Company Qin Xuping and leaders of the Pharmaceutical Company presented awards to the advanced collectives and individuals of the Pharmaceutical Company 2017
2017 respectively. Chairman Jiang Xiaomeng, on behalf of the group company, congratulated the commended advanced collectives and individuals, affirmed the efforts made by all employees of the pharmaceutical company in the past year, and put forward requirements for the work of pharmaceutical company 2018 . He asked pharmaceutical companies to increase talent training; speed up consistency evaluation and new drug research and development; establish the concept of marketing first responsibility, innovate marketing models; expand the scale of retail business; establish and improve internal assessment and incentive mechanisms to mobilize all levels The subjective initiative of personnel. At the
Ni Yingzhen)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page